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Abstract
Background: Genetic mutations in several ubiquitously expressed RNA splicing genes such as PRPF3, PRP31 and PRPC8, have
been found to cause retina-specific diseases in humans. To understand this intriguing phenomenon, most studies have
been focused on testing two major hypotheses. One hypothesis assumes that these mutations interrupt retina-specific
interactions that are important for RNA splicing, implying that there are specific components in the retina interacting with
these splicing factors. The second hypothesis suggests that these mutations have only a mild effect on the protein function
and thus affect only the metabolically highly active cells such as retinal photoreceptors.
Methodology/Principal Findings: We examined the second hypothesis using the PRPF3 gene as an example. We analyzed
the spatial and temporal expression of the PRPF3 gene in mice and found that it is highly expressed in retinal cells relative to
other tissues and its expression is developmentally regulated. In addition, we also found that PRP31 and PRPC8 as well as
snRNAs are highly expressed in retinal cells.
Conclusions/Significance: Our data suggest that the retina requires a relatively high level of RNA splicing activity for
optimal tissue-specific physiological function. Because the RP18 mutation has neither a debilitating nor acute effect on
protein function, we suggest that retinal degeneration is the accumulative effect of decades of suboptimal RNA splicing due
to the mildly impaired protein.
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Introduction
The removal of introns from nascent precursor messenger RNA
(pre-mRNA) transcripts is catalyzed by the spliceosome, a large
and dynamic RNA-protein complex in the cell nucleus [1].
Spliceosome assembly requires sequential formation of a number
of stable macromolecular intermediate complexes, each containing
small nuclear ribonucleoproteins (snRNPs), a pre-mRNA and non-
snRNP-associated proteins. Each snRNP contains one (U1, U2, or
U5) or two (U4 and U6) uridine-rich, small nuclear RNAs
(snRNAs) associated with a set of proteins that are either common
to all snRNPs (Sm and LSm proteins) or specific to a given particle
[2,3]. Hprp3p, the product of the human PRPF3 gene, is one of
the proteins specifically associated with the U4/U6 snRNP
complex [4,5]. Hprp3p is highly conserved from yeast to human,
particularly at its carboxyl terminus. This region is essential for
Hprp3p function by engaging in a network of interactions with
snRNAs and proteins that may stabilize intermediate complexes
required for the assembly of the spliceosome [6]. In particular, the
Hprp3p C-terminus is both necessary and sufficient for binding to
Hprp4p and U4/U6 snRNA. Additionally, it contacts the U4/U6
snRNA recycling factor p110, SPF30 (one of the U2 snRNP
proteins) as well as two U5 snRNP associated proteins, Hprp6 and
Hsnu66 [7,8,9]. Moreover, substitution of threonine-494 for
methionine at the C terminus of Hprp3p is involved in the
etiology of autosomal-dominant retinitis pigmentosa type 18
(RP18) [10].
Retinitis pigmentosa (RP) is one of the most common forms of
retinal degenerative diseases affecting 1 in 4000 people worldwide
[11]. RP defines a heterogeneous group of retinal degenerative
diseases characterized by the gradual structural and functional
disruption of photoreceptor cells, retinal pigment epithelium and
choroid layers [12]. Affected individuals first experience defective
dark adaptation, followed by constriction of the peripheral visual
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Approximately 50 percent of diagnosed individuals have no known
family history of the disease. These cases are called sporadic or RP
simplex [13,14]. The remaining 50 percent of affected individuals
have a known family history. Familial RP displays all three modes
of Mendelian inheritance: autosomal dominant (adRP), autosomal
recessive (arRP) and X-linked (xlRP) [14,15]. The RP-causing
genes are involved in a variety of cellular functions, including the
phototransduction cascade, vitamin A metabolism, cytoskeletal
structure, RNA splicing, cell-cell interaction, trafficking of
intracellular proteins, phagocytosis, pH regulation and others
[11]. The genetic complexity of RP has been highlighted by the
discovery of RP mutations not only in PRPF3 but also in other pre-
mRNA splicing genes (PRPF31 for RP11 and PRPC8 for RP13)
[10,16,17,18]; these splicing genes function not only in the retina
but also throughout the human body [12,17,18,19]. The discovery
of adRP mutations in these genes clearly indicates the importance
of having two wild-type copies of these genes for photoreceptor
survival and function. Currently, the molecular mechanisms by
which ubiquitous pre-mRNA splicing genes confer a tissue-specific
pathogenesis are not clear [20]. However, several theoretical
models have been proposed for testing the underlying mechanisms
such as haploinsufficiency, splicing rate-limitation and disruption
of interactions of splicing factors with photoreceptor-specific
cofactor(s). Here we hypothesize that the retina demands high
levels of splicing components and a slightly reduced level of
splicing activity may have a cumulative and more serious
consequence in photoreceptor cells than in other cell types
because photoreceptors are highly metabolically active [21,22].
In this paper, we examined the temporal and spatial expression
of splicing factors that are directly involved in RNA splicing. We
found that the expression of only RP-associated genes (PRPF3,
PRP31 and PRP8), which encode splicing factors for the U4/U6/
U5 tri-snRNP, is significantly higher in the retina than in other
tissues of adult mice while the expression of genes encoding non-
RP splicing factors is not increased. We also found that levels of
snRNAs, including U1, U2, U4, U5, and U6, are more abundant
in retina than in other tissues. These results indicate that the
postnatal retina requires higher steady-state basal levels of splicing
components than do other metabolically active tissues.
Results
Temporal and spatial expression of PRPF3 mRNA and
protein in mice
Given its role in splicing, PRPF3 is assumed to be ubiquitously
expressed. Even if this is the case, the levels of its expression might
vary in different tissues and developmental stages. If more PRPF3
function is required in retinal cells, we would expect a higher level
of PRPF3 expression in the retina. To examine this idea, we
determined mRNA levels of PRPF3 in mouse tissues at indicated
time points via quantitative RT-PCR. At embryonic day 15.5
(E15.5d) and postnatal day 5 (5d), there was no major difference in
the levels of PRPF3 mRNA among mouse tissues (liver, lung,
kidney, heart, spleen, brain, retina, muscle and intestine).
However, the levels of retinal expression were higher in one-
month (1 m) and four-month (4 m) old mice compared to other
tissues. A high level of PRPF3 mRNA in the retina is sustained in
one-year old mice compared to another neural tissue, brain (Fig. 1a
and Table 1) (p,0.05).
To investigate whether Prpf3 protein expression correlates with
mRNA expression, we examined the levels of Prpf3 protein in
different mouse tissues at different stages of development using
immunoblotting assays (Fig. 1b). As expected, mouse Prpf3 protein
was expressed in all tissues analyzed. Since different organs have
distinct cell types that express different amounts of structural
proteins, a particular structural protein, such as b-actin, cannot be
used as an internal standard because its relative abundance in
various tissues is different. In order to normalize the levels of the
mouse Prpf3 protein, we measured the total protein concentration
from each sample and loaded equal amounts of protein (100 mg)
on SDS-PAGE followed by either immunoblotting or Coomassie
Brilliant Blue staining. We found that the level of Prpf3 protein
expression was similar among different tissues in 5 day and 1
month old mice. However, the level of Prpf3 protein was higher in
the retina than in any of the other tissues examined after the mice
reached adulthood (around 4 months). These protein expression
results are consistent with the RNA expression data. In older mice,
retinal expression of Prpf3 protein decreased to levels similar to
that found in brain tissue.
Localization of PRPF3 mRNA in different types of mouse
retinal cells
Strong retinal expression of PRPF3 does not necessarily mean a
high level of expression in photoreceptor cells since the retina
contains several different cell types. To examine the PRPF3
mRNA distribution in different retinal cells, we performed in situ
hybridization analysis using 4-month old mice (Fig. 2). The
expression of PRPF3 mRNA was detected in all cellular layers of
the retina and a high level of PRPF3 mRNA was observed in
photoreceptor cells. In situ hybridization signals were specific to
PRPF3 as they were not detectable with the sense probe used as a
control. To further validate the in situ conditions, we performed in
situ hybridization using a probe against Chx10 gene that is
primarily expressed in the inner nuclear layer (INL) of the mature
mouse retina [23]. Indeed, we observed Chx10 signals only in this
layer of the retina while no signal was detected using the Chx10
sense probe.
Developmental expression of splicing factors PRPF31,
PRPC8, PRPF4, and U1-, U2-RNP-specific splicing factors in
mouse tissues
Prpf3 is part of U4/U6-U5 tri-snRNP, whereas Prpf31 binds to
the U4 snRNP and Prpc8 interacts with U6 RNA. All the three
splicing genes are ubiquitously expressed and associated with
autosomal dominant RP (RP18, RP11 and RP13, respectively). As
PRPF3 mRNA was highly expressed in the adult mouse retina, we
decided to analyze the developmental expression of the other two
U4/U6-U5 associated genes (PRPF31 and PRPC8). Interestingly,
the mRNA levels of PRPF31 and PRPC8 are very similar to those of
PRPF3. In E15.5d and 5d mice, the mRNA levels of PRPF31 and
PRPC8 were not significantly different among nine different tissues
(Fig. 3a, b). Likewise, the PRPF31 and PRPC8 mRNA levels are
significantly higher in the retina than in all other tissues in four
month old mice. The levels of PRPF31 and PRPC8 mRNA in the
brain are 34–36% of that detected in the retina (Table 1).
As the human PRPF3 gene product, Hprp3p, is stably and
directly associated with the PRPF4 gene product Hprp4p within
the U4/U6 snRNP [6,24], we examined whether the temporal
and spatial expression patterns of the PRPF4 gene in mice are
similar to those observed for PRPF3. Unlike PRPF3, the levels of
PRPF4 mRNA and protein in the retina were not higher than
those in all other tissues (Fig. 3c, d).
In additional to the U4/U6-U5 associated genes encoding
splicing factor Prpf3, Prpf31, Prrpc8 and Prpf4, we also
determined the mRNA levels of genes encoding the U1-70K
protein and U2-SF3a in mouse tissues (Fig. 3e, f). U1-70K is a U1
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snRNP and required for complex A assembly [25]. We found that
the U1-70K protein and SF3a genes were consistently expressed at
low levels in all mouse tissues at various developmental stages.
There was no significantly difference in the mRNA levels of U1-
70K and SF3a among the tissues analyzed.
Levels of snRNAs, U1, U2, U4, U5, and U6 in mouse
tissues
The snRNAs U1, U2, U4, U5, and U6 are major components
of spliceosomes and these highly conserved snRNAs play a central
role in all aspects of the splicing reaction. Previous studies have
shown that Hprp3p is a double stranded RNA binding protein
that specifically contacts U4/U6 snRNAs through both its central
and C-terminal regions [6,26]. Since PRPF3 is highly expressed, it
is possible that snRNAs may also display similar expression
patterns. With that in mind, we analyzed the temporal and spatial
expression patterns of mouse snRNAs using Northern blotting
(Figure S1). We found that there was no significant difference in
the levels of the five snRNAs in 15.5d embryos and postnatal day 5
mouse tissues between the retina and all other tissues (Fig. 4).
However, the levels of all snRNAs are much higher in the retina of
one-month, four-month and one-year old mice than in other
tissues. The levels of U1, U4, U5 and U6 in the retina of four-
month mice were significantly higher than in the brain.
RP18 mutation of PRPF3 does not affect retina-specific
gene expression
Currently, there is no direct evidence indicating that mutations of
PRPF3 affect retina-specific gene splicing in RP18 patients. In a
Table 1. Summary of mRNA levels of splicing factor genes in
retina tissue.
gene E15.5d 5 days 1 month 4 month 1 year
PRPF3 --++ + +
PRPF31 --- ++ ++
PRPC8 --+ + -
PRPF4 - - ---
U1-70K - - ---
U2-SF3a - - ---
+:p ,0.05; ++:p ,0.01 (mRNA levels in retina is significantly higher than that in
brain); -: no difference.
doi:10.1371/journal.pone.0015860.t001
Figure 1. Expression of PRPF3 RNA and protein in mouse tissues. (a) PRPF3 mRNAlevelsinmousetissues.PRPF3mRNAatindicatedtimepoints
detected with real-time RT-qPCR. Total RNA was isolated from liver, lung, kidney heart, spleen, brain, retina, muscle, and intestine (n=3 groups). The
resultwasnormalized with 18S. *=p,0.05, **=p,0.01 retinacompare tobrain.(b)Prpf3 protein in mouse tissues. Prpf3protein detected with Western
blots at indicated time points. E15.5d, embryonic day 15.5; 5d, postnatal day 5; 1 m, one month; 4 m, four months; 1 y, one year.
doi:10.1371/journal.pone.0015860.g001
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defect was observed when the endogenous Hprp3p was replaced by
the RP18 mutant protein via a helper-dependent adenoviral vector
that simultaneously knocks down the endogenous Hprp3p and
expresses a copy of the RP18 mutant PRPF3 [27]. However, it is not
known whether RP18 mutation affects RNA splicing in photorecep-
tor cells. To address this question, we isolated total RNA from the
eyeballs of RP18 knockin mic[28,29] and measured mRNA levels of
several retina-specific genes (including photoreceptor-specific genes)
since a decrease in levels of mRNA may indicate a defect in RNA
splicing.Comparedtothewild-typemice,wedidnotfindadifference
in mRNA levels of RHO (phototransduction gene rhodopsin), NRL
(transcription factor neural retina leucine zipper), RP1 (retinitis
pigmentosa 1 gene) and RDS (photoreceptor structure gene retina
degeneration slow). For comparison, we also examined the mRNA
levels of a house keeping gene, b-2-microglobulin and a single exon
gene Histone 4. These data further demonstrate that RP18 mutation
does not cause a major defect in splicing function, nor does it affect
the splicing of retina-specific and house-keeping genes (Table 2). To
further confirmthis,we examined the effect of the RP18 mutation on
rhodopsin protein expression in mouse retinal primary culture cells.
We transduced the primary cells with a helper-dependent Adenovrial
(HD-Ad) vector expressing shRNAs targeting the endogenous PRPF3
and simultaneously expressing a copy of the wild type or RP18
mutant PRPF3 [30]. Double immunostaining was performed to
detect exogenous Hprp3p tagged with HA and rhodopsin in
photoreceptor cells. We did not detect a noticeable difference in
rhodopsin protein expression in photoreceptor cells between wild-
type and RP18 mutant Hprp3p (Figure S2) suggesting that RP18
mutation of PRPF3 does not affect rhodopsin gene expression in
mouse photoreceptor cells over a short period of time.
Cellular localization of wild-type and RP18 mutant
protein in cultured human retinal epithelial cells
Mutated proteins can change their properties, such as solubility
or cellular distribution, which may lead to pathological symptoms
[31,32]. Therefore, we investigated whether RP18 mutation
altered the cellular localization of Hprp3p in human retinal
epithelial cell lines. Currently there is no PRPF3-deficient
mammalian cell line for studying protein localization. However,
the effect of a dominant mutation can be monitored in cells
transduced with a mutant gene while the endogenous gene
product is knocked down by RNA interference [27]. Small hairpin
RNA was used to specifically silence the endogenous PRPF3
protein while simultaneously expressing HA-tagged human wild-
type or Thr494Met PRPF3, using a viral vector HD-Ad-F3iplus or
HD-Ad-F3iT494M, respectively [27,30]. We found that more
than 90% of the endogenous Hprp3p was knocked down by HD-
Ad-F3iplus or HD-Ad-F3iT494M at two and four days compared
to the empty vector control. The majority of both exogenous wild-
type and mutant Hprp3p proteins was located in nucleus (Fig. 5).
The total levels of the wild-type and mutant Hprp3p protein
expressed in ARP19 cells were similar. The protein from nuclear
fraction was approximately equal to that from the whole cell lysate
in both wild type and mutant human PRPF3 transduced cells as
determined by immunoblotting. This indicated that the majority
Figure 2. Expression of PRPF3 gene in mouse retina. In situ hybridization with an antisense (a) or sense (b) probe against PRPF3. (c and d) In situ
hybridization with an antisense (c) or sense (d) probe against Chx10 gene used as a control for in situ hybridization. Chx10 expression is located in the
inner nuclear layer. ONL: outer nuclear layer, INL: inner nuclear layer, GCL: ganglion cell layer.
doi:10.1371/journal.pone.0015860.g002
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soluble and located in the nucleus. Interestingly, we detected the
presence of Hprp3p in the cytosolic fraction from cells transduced
with viral vectors expressing either wild-type or Thr494Met
PRPF3 at two and four days. We did not observe any Hprp3p
signal in the cytosolic fraction from control cells (transduced with
the empty vector) on the immunoblot, even with longer exposure
(data not shown). The presence of Hprp3p in the cytoplasmic
fraction was unlikely caused by leakage from the nuclear fraction
since nuclear-localized RNA polymerase II was not detected in the
same cytoplasmic fraction. This may have been caused by
overexpression of the exogenous Hprp3 protein. There was no
difference in the levels of cytosolic proteins between the wild-type
and Thr494Met Hprp3p.
Discussion
How mutations in the three genes encoding U4/U6-U5
tri-snRNP associated splicing factors cause adRP is still an
intriguing question. The mutant proteins could theoretically
confer a true dominant phenotype by gaining a function that
produces a detrimental effect on photoreceptor cells (such as
interrupting a cell-specific interaction or generating a cytotoxic
product). Alternatively, the dominant phenotype may be due to
haploinsufficiency. Therefore, analyses of the expression pattern of
these genes will help us gain insight into the RP disease
mechanisms assuming the expression patterns of these splicing
factors in mice and humans are similar.
We performed, for the first time, extensive temporal and spatial
expression analyses of RP-associated splicing factors, Prpf3, Prpf31
and Prpc8, and other splicing factors, Prpf4, U1-70K protein and
SF3a as well as snRNAs in mice in order to gain information on
tissue specific expression and developmental regulation of the
splicing machinery. We found that only RP-associated splicing
factor genes PRPF3, PRPF31 and PRPC8 display a high level of
expression in the retina compared to other tissues, in postnatal
mice. Our studies show that the temporal pattern of this high level
of retinal expression correlates with the visual activity during
Figure 3. Expression of PRPF31, PRPC8, PRPF4, U1-70K and U2 SF3a genes RNA in mouse tissues. (a) PRPF31 mRNA levels in mouse tissues.
PRPF31 mRNA detected by real-time RT-qPCR. **=p,0.01 retina compare to brain. (b) PRPC8 mRNA levels in mouse tissues. *=p,0.05, retina compare
to brain. (c) PRPF4 mRNA levels in mouse tissues. (d) Prpf4 protein in mouse tissues. Prpf4 protein was detected with Western blots at indicated time
points. (e) U1-70K gene mRNA levels in mouse tissues. (f) U2 SF3a gene mRNA levels in mouse tissues. For abbreviations, see the legend in Fig. 1.
doi:10.1371/journal.pone.0015860.g003
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stages, the level of retinal expression of these splicing factors was
comparable to other tissues; this correlates with the lack of visual
activity in these developmental stages. Our results indicate that
postnatal retinas require higher levels of some splicing components
than other metabolically active tissues for daily normal visual
function. We also found that snRNAs are also highly expressed in
retinas in postnatal mice (Fig. 4). With visual function developing,
the levels of snRNAs become higher than any other tissues. The
difference in cell-specific basal levels of RP-associated splicing
factors under normal physiological condition may contribute to
the difference in sensitivity of different cell types to these splicing
factor mutations.
Currently there is no direct evidence suggesting unique
functions for RP-associated splicing factors or showing a high
level of splicing activity in retinal cells. However, it is well known
that photoreceptors are highly specialized, non-dividing cells with
high oxygen consumption and an unusually high metabolic rate
[33,34]. Rod and cone photoreceptors turn over their outer
segments every 10 days. The constant renewal of membranes in
these cells require the active biosynthesis of phospholipids and
neutral lipids, and a high level of expression of both retina-specific
and housekeeping genes, a dynamic transport system and a huge
energy supply. These unique properties make the photoreceptor
cells sensitive to a variety of genetic and environmental insults.
The high demand components for pre-mRNA processes and
oxygenation changes may contribute to the selective vulnerability
of retina in retinitis pigmentosa [35].
The clinical data from RP11 individuals show that the
phenotype of RP11 correlates with the reduced expression level
of PRPF31 mRNA in patients’ lymphoblasts [36]. These clinical
data are consistent with the results of our gene expression analysis
in mice, suggesting that expression levels of RP-associated genes
are important for vision function. The loss of one functional copy
of these essential splicing genes, without compensating expression,
may lead to insufficient function in supporting photoreceptors
especially because of their high demand for mRNA expression and
protein synthesis. Interestingly from the clinical data, the mRNA
level in RP11 asymptomatic carriers was closer to that in control
individuals than to that in symptomatic patients. The level of
PRPF31 mRNA and protein in lymphoblasts from affected
patients was significantly lower than that from asymptomatic
carriers with same mutations [36,37]. This also implies a
compensatory regulation in asymptomatic carriers with RP11
mutation. It is possible that asymptomatic individuals have a
different wild-type PRPF31 allele whose expression may be
elevated to compensate for the functional loss of the mutant allele.
However, genetic studies in mice showed a different picture.
Heterozygous mice with one copy of the PRPF3 or PRPF31 genes
knocked out do not cause retinal degeneration [38,39]. It is
Figure 4. Expression of snRNAs in mouse tissues. U1, U2, U4, U5, U6, and the total snRNAs were detected by Northern blotting with snRNA-
specific probes as described in Materials and Methods and Figure S1. The RNA signals detected with the probes were normalized to 5S rRNA.
*p ,0.05, ** p,0.01 retina compare to brain. For abbreviations, see the legend in Fig. 1.
doi:10.1371/journal.pone.0015860.g004
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symptom or the artificial light conditions in animal facilities are
not appropriate for producing the RP symptom. However, we
cannot rule out the possibility that RP-associated splicing factors
may possess unknown functions required only for processing some
retina-specific transcripts and thus, a decrease in their expression
or in their function due to genetic mutations may lead to RP.
In summary, our study showed that high levels of RP-associated
splicing factors and snRNAs in mouse retinal cells correlate with
the developmental regulation of the visual function. The high level
of expression of these genes in retina may partially explain the
selective vulnerability of retinal cells in the case of RP18, 11 and
13. Although a minor splicing functional defect can be tolerated by
mice which have a shorter life span, it may render an accumulative
effect on retinal degeneration in humans.
Materials and Methods
Animal and tissue sample preparation
Wild type CD-1 female mice were obtained from Charles River
Laboratories and maintained as per guidelines of Sick Kids animal
facilities. The RP18 (Prpf3-T494M/T494M) knockin mice were
described by Graziotto et al.[28]. All animal studies were reviewed
and approved by the Sick Kids institutional committee for humane
use of laboratory animals. Mouse tissues were collected from
different organs at time points as indicated in figure legends and
pooled together. Organs from five mice were pooled together for
each group and three groups were included at each time point.
Retinal material was dissected from eyeballs by circumferential
section of the cornea and removal of the anterior chamber as well
as major blood vessels. Mouse tissues were homogenized in Brij
buffer (1M Tris-HCl pH 7.5, 0.5M EDTE, 5M NaCl, 10% Brij 96
and 10% NP40) with protein inhibitors (complete protease
inhibitor cocktail tablets, Roche) for protein sample preparation
or in Trizol solution for RNA isolation.
Western blot
Protein concentration of tissue lysates was measured, and equal
amounts of protein (100 mg) for each sample were loaded on a
SDS-PAGE followed by either immunoblotting detection or
Coomassie Brilliant Blue staining. Proteins in the SDS-PAGE
gel were transferred electrophoretically to nitrcellulose membrane
and the membrane was blocked in TBST containing 5% nonfat
dry milk and 2% BSA for 2 hour at room temperature. Primary
antibodies against Prpf3 and Prpf4 were described previously [4].
HRP–conjugated anti–rabbit secondary antibodies (Vector Lab-
oratories, Burlingame, CA) were used in conjunction with ECL
reagent (Amersham Pharmacia Biotech, Canada). The proteins on
the blot were detected by X-ray film. Coomassie Brilliant Blue
staining of a separate gel was used to confirm that same amount of
proteins was loaded in each lane.
In situ hybridization
In situ hybridization was performed on mouse retinas with an
antisense RNA probe of Prpf3 with the sense probe as a control
Table 2. mRNA levels of retina specific, splicing factor, and
house keeping genes in the eye of WT and RP18 mice.
PRPF3-WT RP18m
Retina specific genes:
Phototransduction: RHO 11 . 1 3 1
Transcription Factor: NRL 11 . 0 0 1
Transport Gene: RP1 10 . 9 9 8
Photoreceptor Structure Gene: RDS 11 . 0 1 1
pre-mRNA Splicing Factor Genes:
PRPF3 1 1.620*
PRPF31 11 . 0 5 6
PRPC8 11 . 0 4 1
Single Exon Gene:
H4d 10 . 9 5 1
House Keeping Gene:
Beta 2M 11 . 1 5 8
mRNA levels (fold) of retina specific, splicing factor, and house keeping genes in
the eye of WT and RP18 (PRPF3 T494M/T494M) knockin mice, detected by real-
time RT-qPCR, n=5.
*: p,0.05, comparing to WT.
Rho:Rhodopsin; NRL: neural retina leucine zipper; RP1: retinitis pigmentosa 1;
RDS: retina degeneration slow; H4d: Histone cluster 1, H4d; Beta 2M: beta
2-Microglobulin.
doi:10.1371/journal.pone.0015860.t002
2 days
4 days
anti-HA
anti-Hprp3p
Whole cell lysate                     Cytoplasm fraction                   Nuclear fraction 
anti-HA
anti-Hprp3p
  Cont         WT          RP18m         Cont   WT       RP18m          Cont      WT       RP18m
Figure 5. Localization and solubility of WT and RP18 mutant protein. ARPE19 cells were transduced with HD-Ad-F3iplus and HD-Ad-
F3iT494M vectors, which knock down the endogenous PRPF3 expression and express an exogenous copy of wild-type or T494 M mutant PRPF3,
respectively. Control cells were transduced with the HD-Ad empty vector. Proteins in the transduced cells were isolated and fractionated. The
exogenous and the endogenous Hprp3p proteins were detected with an anti-Hprp3p antibody. The anti-HA antibody was used to detect the
exogenous Hprp3p protein only.
doi:10.1371/journal.pone.0015860.g005
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(DIG)-labeled sense and antisense probes for Prpf3 and Chx10
genes were prepared from linearized Prpf3 cDNA plasmid or
Chx10 cDNA plasmid in in vitro transcription using a DIG–RNA
labeling kit (Roche). Retinal sections were fixed in 4% parafor-
maldehyde in PBS, pH 7.6. After treating with triethanolamine
and acetic anhydride, the slides were prehybridized for 2 h at
60uC in a hybridization solution (50% formamide, 5xSSC,
5xDenhardt’s solution, 0.25 mg/ml yeast tRNA, and 0.5 mg/ml
heparin) and then hybridized in the probe-containing hybridiza-
tion solution overnight at 60u. After washing in SSC buffers (26to
0.16 SSC), slides were incubated with anti-digoxygenin–alkaline
phosphatase–Fab fragment in 10% goat serum in TBST overnight
at 4uC. After washing, the color was developed with alkaline
phosphatase substrates (nitroblue-tetrazolium-chloride/5-bromo-
4-chloro-3-indolyl- phosphate) in the dark. Slides were mounted
and photographed.
RNA isolation and real-time q-PCR
Total RNA was extracted using the TRIzol reagent (Invitrogen)
according to manufacturer’s instructions. For qRT–PCR, con-
taminating DNA was removed using RNase-free DNase I. One ug
of RNA was reverse-transcribed using the SuperScript II
(Invitrogen); real-time PCR was performed as described [41].
For relative quantification, PCR signals were compared among
tissues after normalization to 18S rRNA (Ribosomal RNA Control
Reagents, ABI). Fold change was calculated according to Livak
and Schmittgen [28] and normalized to liver tissue. The primers
are listed in Table 3.
Northern blot for detecting snRNAs
For Northern blotting detection of snRNAs in mouse tissues,
equal amounts of total tissue RNA (2 ug) were separated on a 10%
polyacrylamide-urea (8 M) gel, transferred to nylon membrane
(Roche Diagnostics) [42], and UV cross-linked. The membrane-
bond RNA was hybridized using ExpressHybTM (BD Biosciences,
Mississauga, ON, Canada) to
32P-labled oligonucleotide probes
complementary to U1, U2, U4, U5 and U6 snRNAs at 42uC. The
snRNA sequences probed were as follows: U1 (1-79), U2 (8-87),
U4 (1-85), U5 (18-88), U6 (32-99) [42,43], in Figure S3. Blots were
quantified using the PhosphorImager and ImageQuant software,
and normalized with 5S rRNA.
Preparation of HD-Ad vectors
HD-Ad-F3iplus and HD-Ad-F3iT494M were described previ-
ously [30]. Both HD-Ad vectors express shRNAs that target the
endogenous PRPF3 mRNA as well as a copy of HA-tagged
PRPF3 cDNA driven by the human UbC promoter. The HD-Ad-
F3iplus expresses the wild-type human PRPF3 while HD-Ad-
F3iT494M expresses one with the RP mutation (T494M). The
viral vector were prepared as described [27,30].
Cell culture and protein fractionation
ARPE19 cells were cultured in DMEM-F12, supplemented with
10% fetal bovine serum (FBS) (Invitrogen Canada Inc., Burling-
ton, ON, Canada). Cells were transduced at 70% confluency with
HD-Ad-F3iplus or HD-Ad-F3iT494M, or empty HD-Ad vectors
(2500 particles/cell) under serum-free conditions for 2 h, followed
by the addition of media to a final concentration of 10% FBS.
Cells were harvested by scraping 48 h or 96 h post transduction.
The cell pellet from one each 10 cm dish was resuspended in 1 ml
buffer A (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 m M KCl,
0.5 mM DTT, 0.5 mM PMSF, 0.25 mM benzamidine) and
incubated on ice. The cells were re-pelleted and then resuspended
in 300 ml buffer A. For each preparation a 100 ml aliquot was
removed for analysis of whole cell proteins. NaCl was added to this
aliquot to a concentration of 1 M to lyse cell membranes and
release proteins. To the remaining 200 ml of cell suspension, the
detergent Nonidet P-40 was added to a concentration of 0.2% and
the mixture was incubated on ice until all cell membranes were
lysed. The suspension was centrifuged to isolate the supernatant
containing soluble cytosolic proteins. The pellet containing nuclei
and insoluble components was resuspended in 200 ml buffer B
(5 mM HEPES pH 7.9, 1.5 mM MgCl2, 0.2 mM EDTA,
0.5 mM DTT, 0.5 mM PMSF, 0.25 mM benzamidine) and NaCl
was added to a concentration of 1 M. The suspension was then
centrifuged and the supernatant containing soluble nuclear
proteins was preserved [31]. The protein concentration of all
extracts was determined using an ABC protein assay kit (Pierce)
with BSA as a standard. Extracts from cells transduced empty HD-
Table 3. Primers used for real-time RT-qPCR.
Gene FORWARD REVERSE Accession No.
Product
length
PRPF3 GGTGGGACTCGTACATCATAC GGGTAACTGGTGTATCATTGTCA NM_027541 141 bp
PRP4 CCTCCTCCACGACAACCAAA CCCAAAATCCCAGACTCTCC NM_027297 136 bp
PRPF31 GAGAGCACAGAAGGGAAGG GGGCTTCACCTGCTTCACG NM_027328 99 bp
PRPC8 GTGGATGCTCAGAAGGAAGACA GAGGACTGCATGAGGCATGTA NM_138659 141 bp
U1-70K CGGAGAGAGTTTGAGGTGTATG GTGCTTGTAAGCGGAGTGCAT NM_009224 133 bp
U2-SF3a GGAATTTGAGGAGCTGCTGAAG GGTAGCAGTCATGGAGATCAAG NM_029157 119 bp
Rho GCCACACTTGGAGGTGAAATC CCACACCCATGATAGCGTGAT NM_145383 125 bp
NRL CTGTGCCTTTCTGGTTCTGACA GGACTGAGCAGAGAGAGGT NM_008736 83 bp
RP1 GCAGGTTGCATATCCAGTGAC GGAGAAACTAGTAGAAGGTGTGT BC_0996607 123 bp
RDS GGAGGTCAAAGATCGCATCAAG GGTGAGCTGGTACTGGATACA NM_008938 115 bp
H4d CATCACCAAGCCCGCCATC GGAACACCTTCAGCACACCA NM_175654 101 bp
Beta 2M GGTCGCTTCAGTCGTCAGCAT GCAGTTCAGTATGTTCGGCTTC NM_009735 154 bp
Rho:Rhodopsin; NRL: neural retina leucine zipper; RP1: retinitis pigmentosa 1; RDS: retina degeneration slow; H4d: Histone cluster 1, H4d; Beta 2M: beta 2-Microglobulin.
doi:10.1371/journal.pone.0015860.t003
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Western-blotting.
Primary cell culture and immunofluorescent staining
Retinas were isolated in fresh Ringer’s solution and chopped
into small fragments, washed in Ringer’s solution without Ca2+
and Mg2+, supplemented with 0.1 mM EDTA, and incubated in
0.5 ml 0.2% activated papain (Sigma) in the same buffer at 37uC
for 20 minutes. The tissue was dissociated by adding 1 mL of
DMEM/F12 and 15 ml of 10 mg/mL DNase I, and repeated
gentle triturating. Cells were seeded in DMEM/F12 (Gibco),
supplemented with 10% fetal calf serum (FCS; Gibco) and
penicillin-streptomycin (10 IU/L), into 6-well tissue culture plates
containing coverslips previously coated with poly-L-lysine (2 mg/
cm
2 for 2 hours) followed by laminin (1 mg/cm 15 minuts; both
from Sigma–Aldrich). Cells were incubated at 37uCi na
humidified atmosphere of 5% CO2 [44] and were transduced
with HD-Ad-F3iplus and HD-Ad-F3iT494M.
Double immunofluorescent labeling was performed on the
primary culture of mouse retinal cells one week after transduction
with HD-Ad-F3iplus and HD-Ad-F3iT494M vectors. The first
primary antibody against-HA-tag was used to detect exogenous
Prpf3 protein with anti-mouse IgG fluorescence (green). The
endogenous mouse rhodopsin protein was detected by the primary
antibody against-rhodopsin with anti-rabbit IgG conjugated-Cy3
(red) as the secondary antibody. Confocal microscopy was
performed using a Zeiss inverted spinning disk confocal micro-
scope and analyzed with Volocity software (Perkin Elmer Inc.,
Waltham, MA).
Statistical analysis
Student’s t-test or one-way ANOVA followed by Holm’s
multiple comparison was used to compare data pairs or sets,
respectively. Data are presented as mean 6 SEM. p,0.05 was
considered statistically significant.
Supporting Information
Figure S1 A representative Northern blot of snRNAs of
mouse tissues. Northern-blotting was performed as described in
Methods and Materials. The RNA bands are designated on the
right side of the bottom panel. Abbreviations: E15.5d, embryonic
day 15.5; 1 m, one month; 4 m,four months, 1 y, one year; U1,
U1 snRNA; U2, U2 snRNA; U4, U4 snRNA; U5, U5 snRNA;
U6, U6 snRNA, 5S, 5s rRNA; li, liver; lu, lung; ki, kidney; he,
heart; sp, spleen; br, brain; re, retina; mu, muscle; int, intestine.
(TIF)
Figure S2 Expression of wild-type and RP18 mutant
human PRPF3 in mouse photoreceptor cells. Mouse retinal
primary cells were prepared and transduced with viral vectors,
HD-Ad-F3iplus and HD-Ad-F3iT494M (See methods). The
exogenously expressed HA-tagged human Hprp3p protein and
mouse endogenous rhodopsin protein were detected with anti-HA
(green) or anti-rhodopsin antibody (red), respectively, one week
following transduction by double immunofluorescent staining.
DAPI staining was used to show the nuclei.
(TIF)
Figure S3 Oligonucleotides used as probes for snRNA
Northern Blot. For oligo probes used for snRNAs, the
nucleotide positions are provided following the names of the
oligos. These oligo probes were previously used [Cooper M,
Johnston LH, Beggs JD (1995) Identification and characterization
of Uss1p (Sdb23p): a novel U6 snRNA-associated protein with
significant similarity to core proteins of small nuclear ribonucleo-
proteins. Embo J 14: 2066-2075; Patel AA, Steitz JA (2003)
Splicing double: insights from the second spliceosome. Nat Rev
Mol Cell Biol 4: 960-970].
(EPS)
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